Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

NCT04487093 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: neoantigen vaccine + EGFR-TKI
DRUG: neoantigen vaccine + anti-angioge

Sponsor

First Hospital of Shijiazhuang City

Collaborators

[object Object]